Acknowledgement
This study was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIT) (2019R1A2C1002375 and 2021R1A2C2007492). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
References
- Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid cancer. Thyroid 2016;26:1-133 https://doi.org/10.1089/thy.2015.0020
- Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 2006;295:2164-2167 https://doi.org/10.1001/jama.295.18.2164
- Sherman SI, Angelos P, Ball DW, Beenken SW, Byrd D, Clark OH, et al. Thyroid carcinoma. J Natl Compr Canc Netw 2005;3:404-457 https://doi.org/10.6004/jnccn.2005.0021
- Sherman SI, Brierley JD, Sperling M, Ain KB, Bigos ST, Cooper DS, et al. Prospective multicenter study of thyroiscarcinoma treatment: initial analysis of staging and outcome. National Thyroid Cancer Treatment Cooperative Study Registry Group. Cancer 1998;83:1012-1021 https://doi.org/10.1002/(SICI)1097-0142(19980901)83:5<1012::AID-CNCR28>3.0.CO;2-9
- Sakorafas GH, Sampanis D, Safioleas M. Cervical lymph node dissection in papillary thyroid cancer: current trends, persisting controversies, and unclarified uncertainties. Surg Oncol 2010;19:e57-e70 https://doi.org/10.1016/j.suronc.2009.04.002
- Furtado Mde S, Rosario PW, Calsolari MR. Persistent and recurrent disease in patients with papillary thyroid carcinoma with clinically apparent (cN1), but not extensive, lymph node involvement and without other factors for poor prognosis. Arch Endocrinol Metab 2015;59:285-291 https://doi.org/10.1590/2359-3997000000081
- Kim SY, Kwak JY, Kim EK, Yoon JH, Moon HJ. Association of preoperative US features and recurrence in patients with classic papillary thyroid carcinoma. Radiology 2015;277:574-583 https://doi.org/10.1148/radiol.2015142470
- Nam SY, Shin JH, Han BK, Ko EY, Ko ES, Hahn SY, et al. Preoperative ultrasonographic features of papillary thyroid carcinoma predict biological behavior. J Clin Endocrinol Metab 2013;98:1476-1482 https://doi.org/10.1210/jc.2012-4072
- Kim TH, Kim YE, Ahn S, Kim JY, Ki CS, Oh YL, et al. TERT promoter mutations and long-term survival in patients with thyroid cancer. Endocr Relat Cancer 2016;23:813-823 https://doi.org/10.1530/ERC-16-0219
- Xing M, Alzahrani AS, Carson KA, Shong YK, Kim TY, Viola D, et al. Association between BRAF V600E mutation and recurrence of papillary thyroid cancer. J Clin Oncol 2015;33:42-50 https://doi.org/10.1200/JCO.2014.56.8253
- Liu X, Qu S, Liu R, Sheng C, Shi X, Zhu G, et al. TERT promoter mutations and their association with BRAF V600E mutation and aggressive clinicopathological characteristics of thyroid cancer. J Clin Endocrinol Metab 2014;99:E1130-E1136 https://doi.org/10.1210/jc.2013-4048
- Xing M, Liu R, Liu X, Murugan AK, Zhu G, Zeiger MA, et al. BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence. J Clin Oncol 2014;32:2718-2726 https://doi.org/10.1200/JCO.2014.55.5094
- Ryoo I, Kwon H, Kim SC, Jung SC, Yeom JA, Shin HS, et al. Metabolomic analysis of percutaneous fine-needle aspiration specimens of thyroid nodules: potential application for the preoperative diagnosis of thyroid cancer. Sci Rep 2016;6:30075
- Choi SH, Kim EK, Kwak JY, Kim MJ, Son EJ. Interobserver and intraobserver variations in ultrasound assessment of thyroid nodules. Thyroid 2010;20:167-172 https://doi.org/10.1089/thy.2008.0354
- Park CS, Kim SH, Jung SL, Kang BJ, Kim JY, Choi JJ, et al. Observer variability in the sonographic evaluation of thyroid nodules. J Clin Ultrasound 2010;38:287-293 https://doi.org/10.1002/jcu.20689
- Gillies RJ, Kinahan PE, Hricak H. Radiomics: images are more than pictures, they are data. Radiology 2016;278:563-577 https://doi.org/10.1148/radiol.2015151169
- Huang YQ, Liang CH, He L, Tian J, Liang CS, Chen X, et al. Development and validation of a radiomics nomogram for preoperative prediction of lymph node metastasis in colorectal cancer. J Clin Oncol 2016;34:2157-2164 https://doi.org/10.1200/JCO.2015.65.9128
- Huang Y, Liu Z, He L, Chen X, Pan D, Ma Z, et al. Radiomics signature: a potential biomarker for the prediction of disease-free survival in early-stage (I or II) non-small cell lung cancer. Radiology 2016;281:947-957 https://doi.org/10.1148/radiol.2016152234
- Coroller TP, Agrawal V, Narayan V, Hou Y, Grossmann P, Lee SW, et al. Radiomic phenotype features predict pathological response in non-small cell lung cancer. Radiother Oncol 2016;119:480-486 https://doi.org/10.1016/j.radonc.2016.04.004
- Huynh E, Coroller TP, Narayan V, Agrawal V, Hou Y, Romano J, et al. CT-based radiomic analysis of stereotactic body radiation therapy patients with lung cancer. Radiother Oncol 2016;120:258-266 https://doi.org/10.1016/j.radonc.2016.05.024
- Cameron A, Khalvati F, Haider MA, Wong A. MAPS: a quantitative radiomics approach for prostate cancer detection. IEEE Trans Biomed Eng 2015;63:1145-1156 https://doi.org/10.1109/TBME.2015.2485779
- Parmar C, Leijenaar RT, Grossmann P, Rios Velazquez E, Bussink J, Rietveld D, et al. Radiomic feature clusters and prognostic signatures specific for lung and head & neck cancer. Sci Rep 2015;5:11044
- Feldkamp J, Fuhrer D, Luster M, Musholt TJ, Spitzweg C, Schott M. Fine needle aspiration in the investigation of thyroid nodules. Indications, procedures and interpretation. Dtsch Arztebl Int 2016;113:353-359
- Paulson VA, Rudzinski ER, Hawkins DS. Thyroid cancer in the pediatric population. Genes 2019;10:723
- Park VY, Han K, Kim HJ, Lee E, Youk JH, Kim EK, et al. Radiomics signature for prediction of lateral lymph node metastasis in conventional papillary thyroid carcinoma. PLoS One 2020;15:e0227315
- Park VY, Han K, Lee E, Kim EK, Moon HJ, Yoon JH, et al. Association between radiomics signature and disease-free survival in conventional papillary thyroid carcinoma. Sci Rep 2019;9:4501
- Li Y, Han G, Wu X, Li ZH, Zhao K, Zhang Z, et al. Normalization of multicenter CT radiomics by a generative adversarial network method. Phys Med Biol 2021;66:055030
- Aerts HJ, Velazquez ER, Leijenaar RT, Parmar C, Grossmann P, Carvalho S, et al. Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun 2014;5:4006
- Friedman J, Hastie T, Tibshirani R. Regularization paths for generalized linear models via coordinate descent. J Stat Softw 2010;33:1-22 https://doi.org/10.18637/jss.v033.i01
- Mansour J, Sagiv D, Alon E, Talmi Y. Prognostic value of lymph node ratio in metastatic papillary thyroid carcinoma. J Laryngol Otol 2018;132:8-13 https://doi.org/10.1017/S0022215117002250
- Siddiqui S, White MG, Antic T, Grogan RH, Angelos P, Kaplan EL, et al. Clinical and pathologic predictors of lymph node metastasis and recurrence in papillary thyroid microcarcinoma. Thyroid 2016;26:807-815 https://doi.org/10.1089/thy.2015.0429
- Zhou SC, Liu TT, Zhou J, Huang YX, Guo Y, Yu JH, et al. An ultrasound radiomics nomogram for preoperative prediction of central neck lymph node metastasis in papillary thyroid carcinoma. Front Oncol 2020;10:1591
- Tian X, Song Q, Xie F, Ren L, Zhang Y, Tang J, et al. Papillary thyroid carcinoma: an ultrasound-based nomogram improves the prediction of lymph node metastases in the central compartment. Eur Radiol 2020;30:5881-5893 https://doi.org/10.1007/s00330-020-06906-6
- Lu W, Zhong L, Dong D, Fang M, Dai Q, Leng S, et al. Radiomic analysis for preoperative prediction of cervical lymph node metastasis in patients with papillary thyroid carcinoma. Eur J Radiol 2019;118:231-238 https://doi.org/10.1016/j.ejrad.2019.07.018
- Kwak JY, Han KH, Yoon JH, Moon HJ, Son EJ, Park SH, et al. Thyroid imaging reporting and data system for US features of nodules: a step in establishing better stratification of cancer risk. Radiology 2011;260:892-899 https://doi.org/10.1148/radiol.11110206
- Zhou Y, Su GY, Hu H, Ge YQ, Si Y, Shen MP, et al. Radiomics analysis of dual-energy CT-derived iodine maps for diagnosing metastatic cervical lymph nodes in patients with papillary thyroid cancer. Eur Radiol 2020;30:6251-6262 https://doi.org/10.1007/s00330-020-06866-x
- Kil J, Kim KG, Kim YJ, Koo HR, Park JS. Deep learning in thyroid ultrasonography to predict tumor recurrence in thyroid cancers. J Korean Soc Radiol 2020;81:1164-1174 https://doi.org/10.3348/jksr.2019.0147
- Liu T, Zhou S, Yu J, Guo Y, Wang Y, Zhou J, et al. Prediction of lymph node metastasis in patients with papillary thyroid carcinoma: a radiomics method based on preoperative ultrasound images. Technol Cancer Res Treat 2019;18:1533033819831713
- Liang J, Huang X, Hu H, Liu Y, Zhou Q, Cao Q, et al. Predicting malignancy in thyroid nodules: radiomics score versus 2017 American College of Radiology Thyroid Imaging, Reporting and Data System. Thyroid 2018;28:1024-1033 https://doi.org/10.1089/thy.2017.0525
- Park VY, Lee E, Lee HS, Kim HJ, Yoon J, Son J, et al. Combining radiomics with ultrasound-based risk stratification systems for thyroid nodules: an approach for improving performance. Eur Radiol 2021;31:2405-2413 https://doi.org/10.1007/s00330-020-07365-9